Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally

Joint Bone Spine. 2004 Mar;71(2):91-4. doi: 10.1016/j.jbspin.2003.10.007.
No abstract available

Publication types

  • Comparative Study
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / physiopathology
  • Clinical Trials as Topic
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Male
  • Predictive Value of Tests
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / drug effects*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab